Cite

HARVARD Citation

    Caron, B. et al. (2023). Available Methods for Benefit-risk Assessment: Lessons for Inflammatory Bowel Disease Drugs. Journal of Crohn's and colitis. pp. 137-143. [Online]. 
  
Back to record